SignatureFD’s Atossa Therapeutics ATOS Stock Holding History

SignatureFD’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27	Closed	-$608	–	3314
2024 Q3	$608	Buy	+27	New	+$545	﹤0.01%	3070
2022 Q2	–	Sell	-33	Closed	-$1K	–	3103
2022 Q1	$1K	Hold	33	–	–	﹤0.01%	2942
2021 Q4	$1K	Buy	33 +13	+65%	+$476	﹤0.01%	2869
2021 Q3	$1K	Buy	+20	New	+$1.16K	﹤0.01%	2771
2021 Q2	–	Sell	-40	Closed	-$1K	–	2942
2021 Q1	$1K	Buy	+40	New	+$1.46K	﹤0.01%	2588

Other funds holding ATOS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return